Write in a clean editor, then format for Clinical Parkinsonism & Related Disorders in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Clinical Parkinsonism & Related Disorders is a peer-reviewed journal published by Elsevier, covering Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Parkinson's Disease and Spinal Disorders.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Clinical Parkinsonism & Related Disorders 12 (2023) 45–58.
Formats any DOI in Clinical Parkinsonism & Related Disorders style. No sign-up. |
| Publishes research in | Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Parkinson's Disease and Spinal Disorders Balance, Gait, and Falls Prevention Botulinum Toxin and Related Neurological Disorders |
| ISSN | 2590-1125 |
| Citation impact (2-yr) | 1.35 |
| h-index | 23 |
| i10-index | 77 |
| Total citations | 2,582 |
| Article processing charge | $2,400 |
| Open access | Yes |
| Top institutions publishing here | Parkinson's Research and Education Foundation |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Corticobasal degeneration (CBD) is a rare neurodegenerative disorder. The most common presentation of CBD is the corticobasal syndrome (CBS), which is a constellation of cortical and extrapyramidal symptoms and signs. Clinical-pathological studies have illustrated that CBD can present with diverse clinical phenotypes, including a non-fluent, agrammatic primary progressive aphasia syndrome, a behavioral, dysexecutive and visuospatial…
Huntington disease (HD) is a devastating monogenic autosomal dominant disorder. HD is caused by a CAG expansion in exon 1 of the gene coding for huntingtin, placed in the short arm of chromosome 4. Despite its well-defined genetic origin, the molecular and cellular mechanisms underlying the disease are unclear and complex. Here, we review some…
Glucose hypometabolism and insulin resistance increase risk for and accelerate progression in Parkinson's disease and neurocognitive disorders. We conducted a proof of concept trial to determine whether ketogenesis, a metabolic adaptation induced by dietary carbohydrate restriction, can improve cognitive performance in Parkinson's disease patients with mild cognitive impairment. We enrolled patients with mild cognitive impairment…
Pain is a common non-motor symptom of Parkinson's disease (PD) and the prevalence of pain among PD patients varies because of the disease stage, co-morbidities, and evaluating tools. Risk factors for pain in PD include an early age of onset, long disease duration, motor complications, concomitant depressive symptoms, female gender, and associated medical conditions. In…
BACKGROUND: Postural instability (PI) in Parkinson's disease (PD) is associated with several negative downstream consequences. OBJECTIVE: The purpose was to explore the validity of a theoretical model of these downstream consequences arranged in a vicious cycle wherein PI leads to decreased balance confidence, which in turn leads to increased fear of falling (FOF) avoidance behavior,…
